ArticleOncogene2018

Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.

J S K Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.